Author:
Brady B.M.,Amory J.K.,Perheentupa A.,Zitzmann M.,Hay C.J.,Apter D.,Anderson R.A.,Bremner W.J.,Pollanen P.,Nieschlag E.,Wu F.C.W.,Kersemaekers W.M.
Publisher
Oxford University Press (OUP)
Subject
Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine
Reference46 articles.
1. Anawalt BD , Herbst KL, Matsumoto AM, Mulders TM, Coelingh-Bennink HJ and Bremner WJ (2000) Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression. Fertil Steril74,707–714.
2. Anderson RA and Baird DT (2002) Male contraception. Endocr Rev23,735–762.
3. Anderson RA , Wallace AM and Wu FCW (1996) Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5α-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. J Clin Endocrinol Metab81,902–908.
4. Anderson R , Kinniburgh D and Baird D (2002) Etonogestrel implants with depot testosterone: dose-dependent suppression of spermatogenesis for long-acting male contraception. J Clin Endocrinol Metab87,3640–3649.
5. Anderson R , Zhu H, Cheng L and Baird DT (2002) Investigation of a novel preparation of testosterone decanoate in men: pharmacokinetics and spermatogenic suppression with etonogestrel implants. Contraception66,357–64.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献